Current Therapeutic Strategies in Nonalcoholic Fatty Liver Disease
Contents
Chair
Matthew M. Yeh, MD, PhD
Professor of Laboratory Medicine and Pathology, Adjunct Professor of Medicine;
Director, Gastrointestinal and Hepatic Pathology Program, University of Washington, Seattle, WA, USA.
Director, Gastrointestinal and Hepatic Pathology Program, University of Washington, Seattle, WA, USA.
Speaker(s)
Ming-Lung Yu, MD, PhD
Senior Vice President, Dean and Chair Professor, School of Medicine, College of Medicine, National Sun Yat-sen University;
Chair Professor, Hepatitis Research Center, College of Medicine, Kaohsiung Medical University;
Visiting staff, Hepatobiliary Section, Department of Internal Medicine, and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung;
Adjunct Professor, National Pingtung University of Science and Technology, Pingtung, Taiwan.
Topic: Treating Concomitant Disease to Mitigate NASH
Chair Professor, Hepatitis Research Center, College of Medicine, Kaohsiung Medical University;
Visiting staff, Hepatobiliary Section, Department of Internal Medicine, and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung;
Adjunct Professor, National Pingtung University of Science and Technology, Pingtung, Taiwan.
Topic: Treating Concomitant Disease to Mitigate NASH
Takumi Kawaguchi, MD, PhD
Professor and Chairman, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Topic: Therapeutic Strategy for NASH with a Focus in Exercise Therapy
Topic: Therapeutic Strategy for NASH with a Focus in Exercise Therapy
Dan Yock Young, MD, PhD
Chair, University Medicine Cluster;
Senior Consultant, Division of Gastroenterology & Hepatology, Department of Medicine, National University Hospital and National University of Singapore, Singapore, Singapore.
Topic: Phenotype and Lean NASH
Senior Consultant, Division of Gastroenterology & Hepatology, Department of Medicine, National University Hospital and National University of Singapore, Singapore, Singapore.
Topic: Phenotype and Lean NASH
Stephen A. Harrison, MD
Visiting Professor of Hepatology, Radcliffe Department of Medicine, University of Oxford, Oxford, UK;
Chairman- Summit Clinical Research, Chairman- Pinnacle Clinical Research, San Antonio, TX, USA.
Topic: NASH-The Future Looks Bright
Chairman- Summit Clinical Research, Chairman- Pinnacle Clinical Research, San Antonio, TX, USA.
Topic: NASH-The Future Looks Bright
Dean Tai, PhD
Co-founder and Chief Scientific Officer of HistoIndex, Singapore, Singapore.
Topic: Role of Artificial Intelligence and Machine Learning in Therapeutic Strategy of NASH
Topic: Role of Artificial Intelligence and Machine Learning in Therapeutic Strategy of NASH
Programme
Programme
- Time (USA, GMT-8)
- Speakers
- Topics
- 9:00 - 9:05
- Chair (Matthew M. Yeh)
- Opening Remarks and Introduction
- 9:05 - 9:25
- Ming-Lung Yu
- Treating Concomitant Disease to Mitigate NASH
- 9:25 - 9:45
- Takumi Kawaguchi
- Therapeutic Strategy for NASH with a Focus in Exercise Therapy
- 9:45 - 10:05
- Dan Yock Young
- Phenotype and Lean NASH
- 10:05 - 10:15
- /
- Break
- 10:20 - 10:40
- Stephen A. Harrison
- NASH-The Future Looks Bright
- 10:40 - 11:00
- Dean Tai
- Role of Artificial Intelligence and Machine Learning in Therapeutic Strategy of NASH
- 11:00 - 11:20
- /
- Free Discussion (Q&A)
- 11:20 - 11:25
- Chair (Matthew M. Yeh)
- Concluding Remarks
Moments
Presentation
Ming-Lung Yu, Senior Vice President, Dean and Chair Professor, School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Topic: Treating Concomitant Disease to Mitigate NASH
NaN
Stephen A. Harrison, Chairman- Summit Clinical Research, Chairman- Pinnacle Clinical Research, San Antonio, TX, USA.
Topic: NASH-The Future Looks Bright
NaN
Takumi Kawaguchi, Professor and Chairman, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Topic: Therapeutic Strategy for NASH with a Focus in Exercise Therapy
NaN
Dan Yock Young, Senior Consultant, Division of Gastroenterology & Hepatology, Department of Medicine, National University Hospital and National University of Singapore, Singapore, Singapore.
Topic: Phenotype and Lean NASH
NaN
Dean Tai, Co-founder and Chief Scientific Officer of HistoIndex, Singapore, Singapore.
Topic: Role of Artificial Intelligence and Machine Learning in Therapeutic Strategy of NASH
NaN
Free discussion section of the webinar “Current Therapeutic Strategies in Nonalcoholic Fatty Liver Disease”
NaN
